Stockreport

Harpoon Therapeutics Granted Orphan Drug Designation from FDA for HPN217 for Treatment of Multiple Myeloma

Harpoon Therapeutics, Inc.  (HARP) 
Last harpoon therapeutics, inc. earnings: 3/12 04:05 pm Check Earnings Report
PDF SOUTH SAN FRANCISCO, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel cla [Read more]